The management of challenging behaviour in people with dementia

Slides:



Advertisements
Similar presentations
Dementia September 2007 You can add your own organisation’s logo alongside the NICE logo DISCLAIMER This slide set is an implementation tool and should.
Advertisements

Medications in Dementia Patients Dr. DeeDee Hu, PharmD Clinical Coordinator Critical Care Medicine and Cardiology, MHMC Hospital Certified Dementia Care.
A systematic review and health economic analysis of non-drug treatment for agitation associated with dementia Gill Livingston Lynsey Kelly, Elanor Lewis-Holmes,
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Dementia Masterclass December 2013 Types of Dementia, key features, prognostic issues and when to re-refer. Dr A R McMahon ST4 Old Age Psychiatry.
PHARMACOLOGICAL STRATEGIES IN THE MANAGEMENT OF ALZHEIMER’S DISEASE Daniel Varon, MD Wien Center for Alzheimer’s Disease and Memory Disorders.
Management of Challenging Behaviour in Primary Care Daniel Collerton and Karen Franks Gateshead Older People’s Mental Health Service.
Powys-wide, Primary care audit Rhiannon Davies, Powys tHB Medicines Management Team Prescribing of Antipsychotic Medication in Patients with Dementia.
Mental Health Emergencies in Primary Care
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
DEMENTIA. Outline What is Dementia? What is Dementia? Who gets it? Who gets it? What are the symptoms? What are the symptoms? How do we diagnose it? How.
The Right Prescription A Call to Action for junior doctors on the use of antipsychotic drugs for people with dementia.
Current Treatments for Dementia and Future Prospects James Warner St Charles Hospital, London.
Dementia – managing behavioural and psychological symptoms
Dementia Drugs: Mainstream and Alternative Medicines Susan Kurrle.
Management of cognition and communication needs in dementia Dr Vanessa Raymont Consultant Psychiatrist and Honorary Senior Lecturer, West London Mental.
Treatment Options for Dementia Deb Bynum, MD Division of Geriatric Medicine University of North Carolina.
Dementia November This presentation covers: Background Key recommendations Interventions Implementation.
Dementia Conference 2014 Guildford & Waverley Clinical Commissioning Group Dr. Lia Ali Consultant Psychiatrist to G&W Virtual Ward.
Indianapolis Discovery Network for Dementia Translating PREVENT Into Your Practice Caring for your patients with dementia J. Eugene Lammers, MD, MPH Clarian.
Dementia in People with a Learning Disability A Care Pathway Using a Collaborative Approach ANDREW GRIFFITHS.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
The Role Of The Dementia Care Home Liaison Nurse Within South East Essex Jackie Smith Clinical Nurse Specialist Dementia Care Home Liaison Nurse.
Best Practice Guide: Treatment and care for behavioural and psychological symptoms Clive Ballard, Anne Corbett, Alistair Burns Alzheimer’s Society UK.
Dementia Dr Deborah Stinson Sutton CMHT for Older People
Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.
The Confused Elderly Patient Dr C Kotzé Dept of Psychiatry 2012.
Copyright © 2007, 2003 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 37 Confusion and Dementia.
Care of the elderly - dementia
Behavioural and Psychological Symptoms of Dementia Non-pharmacological and pharmacological approaches Dr Joy Ratcliffe, Consultant Psychiatrist Dr Julie.
THE EFFECT OF EXERCISE ON BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA: A REVIEW OF THE LITERATURE Dr. Ingela Thuné-Boyle Prof. Steve Iliffe UCL,
Alasdair MacLullich Professor of Geriatric Medicine Consultant in Geriatric Medicine University of Edinburgh.
Treating Behavioral and Psychological Symptoms of Dementia (BPSD) Kuang-Yang Hsieh, M.D. ph.D. Department of Psychiatry Chimei Medical Center.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
CONFUSION & DEMENTIA CHAPTER 35.
Cognitive Responses and Organic Mental Disorders
Wicking Dementia Research and Education Centre IS IT DEPRESSION, IS IT DEMENTIA OR BOTH? Dr Joanna Bakas Consultant Psychiatrist Dr Kate-Ellen Elliott.
10 slides on… Delirium in older people with CKD Dr Miles D Witham University of Dundee.
Further knowledge in dementia part 2. Welcome Introductions Group Agreement What will be achieved from this session? South West Dementia PartnershipFurther.
Use of Antipsychotic Drugs in Dementia Josepha A. Cheong, MD University of Florida Departments of Psychiatry and Neurology Chief, Division of Geriatric.
DEMENTIA ABDULMAJEED ALOLAYAH What is DEMENTIA ? It is a chronic global impairment of cognitive functions without disturbed consciousness.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Dementia Care Wendy Burnett CNS for Older People.
Prescribing in Dementia. Plan What to prescribe? When to prescribe? How to review? Who to review?
CONFUSION AND DEMENTIA Copyright © 2004 Mosby, Inc. All rights reserved.Slide 0.
BIPOLAR DISORDER, DR GIAN LIPPI CONSULTANT PSYCHIATRIST UNIVERSITY OF PRETORIA & WESKOPPIES HOSPITAL FORENSIC UNIT MANAGEMENT GUIDELINES.
Memantine (Ebixor) Joanne Lily Wombwell Senior Memory Clinic Nurse Hartington Unit, CNDRH.
DR JOHAN SCHOEMAN ACTING CONSULTANT PSYCHIATRIST OLDER PEOPLE’S MENTAL HEALTH SERVICES (SOUTH BEDFORDSHIRE AND LUTON) Basics of Dementia.
Dementia 3 rd. edition – August 2011 NICE clinical guideline 42 Implementing the NICE/SCIE guidance.
© The Association for Dementia Studies Dementia, and why it matters. Bernie Coope, Associate Medical Director, WHACT Honorary Senior Lecture, University.
Antipsychotic use in patients with dementia – How are we doing? Project Team Dr Seema Gupta, Consultant OPMH YGC, Audit Lead Elizabeth Bond, MH pharmacist.
ALZHEIMER’S DISEASE AHII.
Why Mental Health? Dr Ed Beveridge Consultant Psychiatrist Wednesday August 24th 2016 Stephenson House.
Advancing practice in the care of people with dementia
Pharmacological management of delirium
Dementia and Medication Considerations
Anxiety Treatment Guidelines
SIGN GUIdeline: diagnosis and management of delirium
Introduction to Dementia
Neurocognitive Disorders
Polypharmacy and specific medication profiles as predictors of treatment and health outcomes in dementia Dr Christoph Mueller, NIHR Academic Clinical Lecturer.
Management of Agitation in Dementia
Dr Anna Kolliakou NIHR Biomedical Research Centre
SOUTH WORCESTERSHIRE CARE NAVIGATORS AWARENESS TRAINING
Physical Health and Dementia, Delirium and Pain
Alzheimer’s Disease Medical University of Sofia, Faculty of Medicine
University of Nizwa College of Pharmacy and Nursing School of Pharmacy
Polypharmacy Pharmacist Consultant Liz Butterfield FRPharmS
Dr James Ovens Consultant Psychiatrist Tandridge CMHRS
Palliative and End of Life Care for patients with Dementia
Presentation transcript:

The management of challenging behaviour in people with dementia Dr G Theodoulou Consultant Older Adult Psychiatrist 7.9.16

Who am I?

Dementia Decline in two cognitive domains Impairment of ADLS Brain disease Six months duration Not easily reversible

Mind your language! Dementia sufferer Demented Senile or senile dementia Burden e.g. people are a burden or cause burden Victim Plague Epidemic Enemy of humanity Living death e.g. dementia is a living death

Person with dementia ‘Person centred care’- Kitwood 1997 Uniqueness of every individual’s experience of dementia

Behaviour that challenges ………..a manifestation of distress in the person with dementia or of distress in the carer…… Bird and Moniz-Cook 2008

What are the behaviours that challenge? Perceived aggression Agitation or restlessness; screaming Anxiety Depression Psychosis, delusions, hallucinations Repetitive vocalisation, cursing and swearing Sleep disturbance Shadowing (following the carer closely) Sundowning Travelling alone causing concern Non-specific behaviour disturbance e.g. hoarding, putting food in wardrobe

Newcastle model framework (James 2011)

Mental health, care home in-reach MH nurses Intensive input Smaller caseload (cf OACMHT) Use Newcastle model Use medication Consultant OA psych support Available in south Worcestershire Access via OACMHT

Medication for challenging behaviour Acetylcholinesterase inhibitors Memantine Benzodiazepines Antipsychotics Antidepressants Miscellaneous Consider capacity to consent, best interest decision + LPA for H&W

Acetylcholinesterase inhibitors Donepezil, Galantamine and Rivastigmine AD and DLB/PDD only May alleviate agitation May cause agitation May reduce psychosis Specialist initiation

Memantine Licensed for AD only NMDA receptor antagonist Reduces agitation Reduces psychosis Specialist initiation Can take up to 3 months for +ve effects

Benzodiazepines For rapid tranquilisation Lorazepam best Avoid diazepam- active long half life metabolite IMO- first line when there is severe distress or behaviour that puts PWD in harms way 0.25mg -0.5mg prn, Max 1.5mg/24hrs

Antipsychotics in dementia(1) Best avoided unless distressing psychosis, general severe distress or harmful behaviour Do more harm than good Only 10% gain benefit Increase risk of stroke, infection, DVT, MI, arrhythmia, constipation, dehydration, early death Before prescribing should try to evidence psycho-social intervention ineffective or not practicable

Antipsychotics (2) Risperidone 0.25mg to 1mg/24hrs Olanzapine 2.5mg to 5mg/24hrs Aripiprazole 2.5mg to 10mg/24hrs

Antidepressants in dementia High rate of depression in all dementias Best evidence for mirtazapine Mirtazapine 15-45mg/24hrs Sertraline 25-150mg/24hrs Venlafaxine 37.5-150mg/24hrs

Others Carbamazepine Pregabalin Melatonin Zopiclone Trazadone

….so in conclusion, the last professional a PWD and challenging behaviour needs to see is a psychiatrist!